Table 1.

Clinical and demographic characteristics of patients

Procedure		42 (22 patients)
Age (years)	median (IQR)	15.1 (12.7–17.4)
Male/Female		33/9
Height (cm)	mean ± SD	159.3 ± 11.3
Body weight (kg)	mean ± SD	50.5 ± 10.7
Body mass index (kg/m2)	mean ± SD	19.7 ± 3.0
Growth height z-score	mean ± SD	–0.7 ± 2.6
PCDAI	median (IQR)	5.0 (0–15.0)
Treatment
	5-ASA	81.0% (34/42)
	Azathiopurine (or 6-mercaptopurine)	52.4% (22/42)
	Prednisolone	0% (0/42)
	Infliximab	23.8% (10/42)
	Others (no medication or herbal medicine)	14.3% (6/42)

Abbreviations are referred following. PCDAI, Pediatric Crohn’s Disease Activity Index (clinical remission; <10); 5-ASA, 5-aminosalicylic acid.